SecSonar.com

CareDx, Inc (CDNA)

CareDx, Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

CareDx, Inc (CDNA) is a Medical - Diagnostics & Research company based in US with a market capitalization of $1.2B. Revenue grew 13.8% year-over-year and the company generated $36.1M in free cash flow. This page tracks CDNA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 644 employees · IPO Jul 17, 2014

Valuation

Valuation & price

$19.97 · as of May 17, 2026 · -31.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.90

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$29.19$20.38$11.57Jul 25Dec 25Jul 26Jul 7, 25$18.45Jul 9, 25$20.28Jul 11, 25$20.13Jul 15, 25$19.01Jul 17, 25$11.81Jul 21, 25$12.75Jul 23, 25$13.12Jul 25, 25$12.79Jul 29, 25$12.72Jul 31, 25$12.29Aug 4, 25$12.60Aug 6, 25$13.10Aug 11, 25$11.77Aug 13, 25$12.13Aug 15, 25$11.84Aug 19, 25$11.57Aug 21, 25$12.51Aug 25, 25$12.75Aug 27, 25$13.29Aug 29, 25$13.66Sep 3, 25$12.73Sep 5, 25$13.82Sep 9, 25$13.45Sep 11, 25$13.53Sep 16, 25$14.18Sep 18, 25$14.77Sep 22, 25$14.99Sep 24, 25$15.06Sep 26, 25$14.93Sep 30, 25$14.54Oct 2, 25$14.84Oct 6, 25$14.96Oct 8, 25$14.79Oct 10, 25$14.39Oct 14, 25$14.35Oct 16, 25$14.99Oct 21, 25$15.19Oct 23, 25$14.70Oct 27, 25$14.51Oct 29, 25$14.28Oct 31, 25$15.00Nov 4, 25$14.52Nov 6, 25$15.01Nov 10, 25$16.70Nov 12, 25$16.31Nov 14, 25$15.94Nov 18, 25$15.76Nov 20, 25$15.76Nov 25, 25$17.90Nov 28, 25$17.87Dec 2, 25$17.44Dec 4, 25$19.41Dec 8, 25$18.90Dec 10, 25$19.55Dec 12, 25$20.56Dec 16, 25$19.36Dec 18, 25$19.19Dec 22, 25$20.02Dec 24, 25$19.73Dec 29, 25$19.20Jan 2, 26$19.14Jan 6, 26$18.81Jan 8, 26$17.22Jan 12, 26$20.57Jan 14, 26$20.32Jan 16, 26$20.01Jan 21, 26$20.83Jan 23, 26$20.42Jan 27, 26$20.58Jan 29, 26$20.80Feb 2, 26$20.42Feb 4, 26$18.93Feb 9, 26$20.19Feb 11, 26$19.72Feb 13, 26$19.63Feb 18, 26$19.93Feb 20, 26$18.80Feb 24, 26$19.25Feb 26, 26$18.82Mar 2, 26$18.75Mar 4, 26$19.06Mar 6, 26$17.89Mar 10, 26$16.98Mar 12, 26$16.45Mar 17, 26$17.60Mar 19, 26$17.59Mar 23, 26$17.56Mar 25, 26$18.08Mar 27, 26$16.78Mar 31, 26$17.36Apr 2, 26$18.31Apr 7, 26$17.67Apr 9, 26$16.69Apr 13, 26$16.83Apr 15, 26$17.57Apr 17, 26$21.42Apr 22, 26$20.63Apr 24, 26$21.23Apr 28, 26$21.91Apr 30, 26$20.81May 4, 26$20.96May 6, 26$20.95May 8, 26$21.82May 12, 26$21.40May 14, 26$20.49May 18, 26$20.59May 20, 26$21.15May 22, 26$21.63May 28, 26$22.70Jun 1, 26$22.80Jun 3, 26$22.31Jun 5, 26$22.25Jun 9, 26$22.75Jun 11, 26$23.66Jun 15, 26$24.08Jun 17, 26$23.48Jun 22, 26$25.05Jun 24, 26$27.13Jun 26, 26$28.82Jul 2, 26$29.19
$11.5752-week range$29.28
Loading valuation history…

Fundamentals

Key fundamentals

$1.2B

Market cap

13.8%

Revenue growth (YoY)

67.0%

Gross margin

$36.1M

Free cash flow (USD)

-$157.5M

Net debt

Net cash position

1.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$40.6MFY 2017$48.3MFY 2018$76.6MFY 2019$127.1MFY 2020$192.2MFY 2021$296.4MFY 2022$321.8MFY 2023$280.3MFY 2024$333.8MFY 2025$379.8M
$40.6M$379.8M

Free cash flow by year

2016 → 2025

FY 2016$-17.1MFY 2017$-14.5MFY 2018$-11.2MFY 2019$-6.1MFY 2020$23.1MFY 2021$-39.6MFY 2022$-49.6MFY 2023$-27.6MFY 2024$31.6MFY 2025$36.1M
-$17.1M$36.1M

Gross margin by year

2021 → 2025

FY 202167.1%FY 202265.1%FY 202363.6%FY 202467.2%FY 202567.0%
67.1%67.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

8

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 28, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $1.2M · 10b5-1 PlanHanna John Walter JR · Director, President and CEO · $1.2MJun 30, 2026Filing
  • Insider sellInsider Sell $425K · 10b5-1 PlanHanna John Walter JR · Director, President and CEO · $424.9KJun 17, 2026Filing
  • Insider sellInsider Sell $280K · 10b5-1 PlanValantine Hannah · Director · $279.7KJun 16, 2026Filing
  • Insider sellInsider Sell $528K · 10b5-1 PlanHanna John Walter JR · Director, President and CEO · $528.4KJun 15, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 15, 2026Filing
  • Insider sellInsider Sell $116K · 10b5-1 PlanHanna John Walter JR · Director, President and CEO · $116KJun 8, 2026Filing
  • Insider sellInsider Sell $215KTORRES ARTHUR A · Director · $214.7KMay 18, 2026Filing
  • Insider sellInsider Sell $56K · 10b5-1 PlanNovack Jeffrey Adam · Secretary and General Counsel · $55.6KMay 6, 2026Filing
  • 8-K eventMerger AgreementApr 28, 2026Filing
  • Quarterly report10-Q FiledApr 28, 2026Filing

Questions

Frequently asked questions

What is CareDx, Inc's market cap?

CareDx, Inc (CDNA) has a market capitalization of $1.2B.

What is CDNA's P/E ratio?

A meaningful P/E ratio is not available for CDNA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CDNA's price-to-book (P/B) ratio?

CDNA trades at 3.90 times book value per share.

Are insiders buying CDNA stock?

SEC Form 4 filings show no open-market insider buys at CareDx, Inc in the last 90 days (8 sells).

Same arena

Related companies in Medical - Diagnostics & Research

PSNL

Personalis, Inc.

$1B

CSTL

Castle Biosciences, Inc.

$640.9M

FLGT

Fulgent Genetics, Inc.

$528.9M

MYGN

Myriad Genetics, Inc.

$378.3M

PRE

Prenetics Global Limited

$360.1M

NEOG

Neogen Corporation

$2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.